Abstract

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)

Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P

Issue: Jan/Feb 2022 - Volume 26, Number 1

Page(s): 72-79

Download in electronic PDF format for $75
  • Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Page 1
  • Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Page 2
  • Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Page 3
  • Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Page 4
  • Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Page 5
  • Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Page 6
  • Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Page 7
  • Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Page 8

Abstract

Closed-system transfer devices mitigate occupational exposure risks associated with hazardous-drug handling. This study was conducted in a controlled laboratory to evaluate the effectiveness of a needle-free and a needle-based closed-system transfer device in minimizing surface contamination during simulated compounding, preparation, and administration. A needle-based and a needle-free closed-system transfer device underwent three trials per system. Each trial included reconstituting cyclophosphamide in a vial, withdrawing cyclophosphamide from the vial, and pushing cyclophosphamide into an intravenous bag. After every trial, wipe samples were collected from five sources: biological safety cabinet workbench (left and right sides), biological safety cabinet grill, biological safety cabinet airfoil, and technicians’ gloves. Wipe samples were then analyzed using high-performance liquid chromatography with dual-mass spectrometry to measure cyclophosphamide concentrations. Surface contamination levels from 30 post-trial tests (15 per device) are reported, representing five different surface wipe samples from three trials for each device. Pre-trial samples of precleaned vials and work surfaces were obtained to ensure no cyclophosphamide contamination. Field blank samples were analyzed for quality-control purposes. Post-trial wipe sample analyses following each of the three needle- free trials did not detect cyclophosphamide on the biological safety cabinet workbench (both left/right), biological safety cabinet grill, biological safety cabinet airfoil, or the technician’s gloves. For the needle-based closed-system transfer device, the wipe sample analyses after the first trial showed no contamination; however, cyclophosphamide was detected on the right biological safety cabinet workbench at concentrations of 0.223 ng/cm2 and 0.021 ng/cm2, respectively, following the second and third trials. No cyclophosphamide was found on the technician’s gloves after any of the three needle- based closed-system transfer device trials. Based on surface contamination analyses, this study verified the ability of a needle-free closed-system transfer device in preventing the escape of cyclophosphamide during simulated compounding and preparation. Needle-free closed-system transfer devices warrant consideration for the handling of hazardous drugs.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2022
Pg. 72-79
Nov/Dec 2021
Pg. 515-522
Sep/Oct 2012
Pg. 431-433
Mar/Apr 2016
Pg. 148-154
Sep/Oct 2022
Pg. 358-362
Nov/Dec 2006
Pg. 446-448
Author(s): Allen Loyd V Jr
Jan/Feb 2015
Pg. 30-37
Nov/Dec 2019
Pg. 454-461
Mar/Apr 2023
Pg. 154-159
Jan/Feb 2020
Pg. 30-36
Author(s): Dillon L R
Mar/Apr 2014
Pg. 94-99
Author(s): Marks Zach
Mar/Apr 2023
Pg. 169-174
Jul/Aug 2018
Pg. 345-349
May/Jun 2021
Pg. 211-216
Author(s): Mulder Kyle
Mar/Apr 2013
Pg. 100-110
Nov/Dec 2012
Pg. 446-450
Author(s): Pore R David
Jul/Aug 2023
Pg. 340-346
Sep/Oct 2020
Pg. 426-433
Nov/Dec 2022
Pg. 497-504
Author(s): Summers Amy
May/Jun 2019
Pg. 182-186
Author(s): Dillon L Rad